Johnson & Johnson in talks to acquire Protagonist Therapeutics, source says
Johnson & Johnson is in discussions to buy Protagonist Therapeutics, a source familiar with the matter told Reuters. Shares of Protagonist surged more than 30% in afternoon trading.
October 10, 2025
All the delicious ways you can reduce food waste in the kitchen
Couple carries on late son's legacy of public service
Tunisia frees prominent lawyer Sonia Dahmani, a critic of the president
Putin sees US peace plan as a starting point as he warns Ukraine's army to withdraw
Putin says it's senseless to sign documents with 'illegitimate' Ukrainian leadership
Dutch prosecutor fines Morgan Stanley 101 million euros for tax evasion
Sally Rooney says UK ban on Palestine Action could force her books off shelves